Somatic mutations render human exome and pathogen DNA more similar.
Immunotherapy has recently shown important clinical successes in a substantial number of oncology indications. Additionally, the tumor somatic mutation load has been shown to associate with response to these therapeutic agents, and specific mutational signatures are hypothesized to improve this asso...
Main Authors: | Ehsan Ebrahimzadeh, Maggie Engler, David Tse, Razvan Cristescu, Aslan Tchamkerten |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0197949 |
Similar Items
-
NSAID use and somatic exomic mutations in Barrett’s esophagus
by: Patricia C. Galipeau, et al.
Published: (2018-02-01) -
Exome-wide somatic mutation characterization of small bowel adenocarcinoma.
by: Ulrika A Hänninen, et al.
Published: (2018-03-01) -
Correction to: NSAID use and somatic exomic mutations in Barrett’s esophagus
by: Patricia C. Galipeau, et al.
Published: (2019-03-01) -
Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors
by: Pereira Luísa, et al.
Published: (2012-02-01) -
Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.
by: Anne Bruun Krøigård, et al.
Published: (2016-01-01)